Founded in 1945 as a closed city codenamed Sverdlovsk-44, Novouralsk produced High Enriched Uranium for the USSR’s nuclear weapons program. It is home to the Ural Electrochemical Combine, the oldest and largest enrichment facility in Russia and one of four in the country manufacturing low enriched uranium for nuclear power reactors today.^[1] Global shifts from nuclear power have impacted the uranium enrichment industry. To remain competitive, UECC restructured between 2009 and 2011, reducing the workforce from 15,000 to 5,000. With few alternative equivalent jobs available, the town began losing its younger population. Novouralsk aims to intensify its strengths in the science and technology sectors. Its socio-economic development plan features Medsintez, a pharmaceutical company producing genetically engineered human insulin, in a high-tech industrial park.